Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.00043302676447239314,2.258433283358321,17.490913137915708,"['PFKFB2', 'PFKFB1', 'LAMA5', 'CRTC2', 'CSF1', 'CAB39L', 'IRS1', 'TNC', 'PIK3CD', 'IRS2', 'SLC2A4', 'PIK3C2A', 'IGF1R', 'CREB3L4', 'TNR', 'IFNAR2', 'HSP90AA1', 'EGF', 'HGF', 'OSMR', 'VEGFA', 'EFNA1', 'COL5A1', 'FGFR3', 'EPHA2']",0.08051001158029973,0,0,25
2,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.0005583249126112472,2.815467563337005,21.08945541418615,"['EGR1', 'SNAP25', 'CEBPB', 'CHRNA4', 'BDNF', 'GCK', 'NFKB2', 'VEGFA', 'ADCYAP1', 'PRKAR2B', 'PAH', 'BHLHE40', 'HES1', 'YWHAG', 'HES5', 'YWHAH']",0.08051001158029973,0,0,16
3,Nuclear Receptors Meta-Pathway WP2882,0.0005742303520164375,2.252042769762338,16.805823975390737,"['EGR1', 'NQO1', 'HSP90AA1', 'SRXN1', 'HGF', 'AMIGO2', 'SLC39A11', 'IRS2', 'DBI', 'NRG1', 'SLC2A4', 'SLC5A3', 'SLC39A14', 'NFKB2', 'CYP3A7', 'FASN', 'ENC1', 'BHLHE40', 'HMOX1', 'HES1', 'EPHA2', 'SLC19A2', 'HSPA1A', 'FKBP5']",0.08051001158029973,0,0,24
4,IL-18 signaling pathway WP4754,0.0008120049453965381,2.2806490384615383,16.229107970914573,"['CEBPB', 'NRN1', 'HSPB8', 'IL18', 'PLOD3', 'HSPB1', 'TNFRSF11B', 'KLF2', 'VEGFA', 'NFKB2', 'TNFRSF1A', 'ACTA2', 'SOCS3', 'NR4A1', 'CLDN4', 'NFKBIZ', 'HMOX1', 'FAS', 'CYCS', 'KIFC3', 'PTPN7', 'MYD88']",0.08051001158029973,0,0,22
5,Differentiation Pathway WP2848,0.0009338729999551639,6.56989247311828,45.832687453079295,"['NT5E', 'CSF1', 'EGF', 'HGF', 'WNT7B', 'VEGFA']",0.08051001158029973,0,0,6
6,Vitamin D Receptor Pathway WP2877,0.0014506243220492189,3.044402751719825,19.89748952886722,"['SERPINB1', 'CEACAM1', 'BCL6', 'GADD45A', 'S100A6', 'NFATC2', 'CD9', 'PRKCQ', 'TNFRSF11B', 'SLC2A4', 'ATP2C2', 'ZNF257']",0.08051001158029973,0,0,12
7,Complement system WP2806,0.0014843681042211606,4.244500478219285,27.64343889529042,"['LAMA5', 'C1R', 'PROS1', 'CFI', 'F11', 'SERPING1', 'CD59', 'KLKB1']",0.08051001158029973,0,0,8
8,Complement and Coagulation Cascades WP558,0.0015735006286937444,5.7960151802656545,37.41010433360576,"['C1R', 'PROS1', 'CFI', 'SERPING1', 'F3', 'KLKB1']",0.08051001158029973,0,0,6
9,MAPK Signaling Pathway WP382,0.002003931695116617,2.1069999364797054,13.090040893923751,"['IL1R1', 'GADD45A', 'BDNF', 'EGF', 'HSPB1', 'NFATC1', 'HSPA2', 'NFKB2', 'TNFRSF1A', 'NR4A1', 'MRAS', 'FLNA', 'FAS', 'TAB2', 'PTPN7', 'MAP3K6', 'CACNG2', 'FGFR3', 'MAP3K14', 'HSPA1B', 'HSPA1A', 'MAP2K6']",0.08051001158029973,0,0,22
10,Globo Sphingolipid Metabolism WP1424,0.0021917341122076844,6.836129753914989,41.858047802803185,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'FUT2', 'A4GALT']",0.08051001158029973,0,0,5
11,Osteoblast differentiation WP4787,0.002261650703849498,2.8669730175562624,17.464625805041965,"['FZD1', 'HES6', 'NOTCH3', 'SMAD1', 'FZD5', 'WNT7B', 'FZD9', 'SMAD9', 'PIK3CD', 'PRKCQ', 'PIK3C2A', 'FGFR3']",0.08051001158029973,0,0,12
12,NRF2 pathway WP2884,0.0023327286764187397,2.714185115847689,16.449906762269368,"['EGR1', 'NQO1', 'HSP90AA1', 'SRXN1', 'HGF', 'SLC39A11', 'NRG1', 'SLC2A4', 'SLC5A3', 'SLC39A14', 'HMOX1', 'EPHA2', 'HSPA1A']",0.08051001158029973,0,0,13
13,Signal transduction through IL1R WP4496,0.002500898660832503,5.185059422750425,31.06423619704283,"['IRAK2', 'IL1R1', 'IL1RAP', 'MAP3K14', 'MYD88', 'MAP2K6']",0.08051001158029973,0,0,6
14,Adipogenesis WP236,0.002572223842635359,2.6800373134328357,15.98102081421744,"['FZD1', 'CEBPB', 'IRS1', 'GADD45A', 'EBF1', 'IRS2', 'SLC2A4', 'SOCS3', 'KLF6', 'BMP1', 'PNPLA3', 'FAS', 'RXRG']",0.08051001158029973,0,0,13
15,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.0026541762059439475,2.9706515228820516,17.620778816244496,"['MRAS', 'SHC1', 'EGF', 'HGF', 'GAB1', 'PLCG2', 'PIK3CD', 'NRG1', 'FGFR3', 'IGF1R', 'VEGFA']",0.08051001158029973,0,0,11
16,Vitamin A and carotenoid metabolism WP716,0.003094796590459131,4.925403225806452,28.459142854728466,"['RBP4', 'RBP2', 'RBP1', 'BCO2', 'BCO1', 'RXRG']",0.08800827804118154,0,0,6
17,Blood Clotting Cascade WP272,0.0033646441043157335,16.37483266398929,93.24538889014518,"['F11', 'F3', 'KLKB1']",0.09005370985080347,0,0,3
18,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.005051191473114574,3.3716220886032207,17.829579719448102,"['IL1R1', 'IRAK2', 'IRF7', 'TAB2', 'IL1RAP', 'MAP3K14', 'MYD88', 'MAP2K6']",0.12211989298779703,0,0,8
19,Hypertrophy Model WP516,0.0051884507290455096,7.283884420613643,38.322847778838714,"['IL1R1', 'IFRD1', 'IL18', 'VEGFA']",0.12211989298779703,0,0,4
20,Breast cancer pathway WP4262,0.00549293252435357,2.331796223100571,12.135350781433424,"['FZD1', 'NOTCH3', 'FZD5', 'SHC1', 'GADD45A', 'EGF', 'WNT7B', 'FZD9', 'PIK3CD', 'IGF1R', 'NFKB2', 'FRAT2', 'HES1', 'HES5']",0.12211989298779703,0,0,14
21,Gene regulatory network modelling somitogenesis  WP2854,0.00563630275328294,12.28012048192771,63.59293509369632,"['LFNG', 'HES1', 'TBX6']",0.12211989298779703,0,0,3
22,Endochondral Ossification with Skeletal Dysplasias WP4808,0.0073141217358366805,3.4835841592234593,17.132086846612445,"['ADAMTS1', 'COL10A1', 'SLC38A2', 'FGFR3', 'IGF1R', 'DDR2', 'VEGFA']",0.133550125319237,0,0,7
23,Endochondral Ossification WP474,0.0073141217358366805,3.4835841592234593,17.132086846612445,"['ADAMTS1', 'COL10A1', 'SLC38A2', 'FGFR3', 'IGF1R', 'DDR2', 'VEGFA']",0.133550125319237,0,0,7
24,Heart Development WP1591,0.00733791897358445,4.823529411764706,23.706199976557308,"['SMAD1', 'BHLHE40', 'NFATC2', 'NFATC1', 'VEGFA']",0.133550125319237,0,0,5
25,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.00733791897358445,4.823529411764706,23.706199976557308,"['HSP90AA1', 'ACAP1', 'IL18', 'ERBIN', 'NOD1']",0.133550125319237,0,0,5
26,Insulin Signaling WP481,0.007850488520475816,2.094892089442498,10.154318026724338,"['EGR1', 'SNAP25', 'XBP1', 'IRS1', 'SHC1', 'GAB1', 'PIK3CD', 'IRS2', 'SLC2A4', 'PIK3C2A', 'IGF1R', 'SOCS3', 'PRKCQ', 'MAP3K6', 'MAP3K14', 'MAP2K6']",0.13738354910832679,0,0,16
27,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.00893915039651749,4.555182699478001,21.4882304381596,"['FZD1', 'BMP1', 'P3H2', 'TNFRSF11B', 'COLGALT1']",0.14577719728247035,0,0,5
28,IL-1 signaling pathway WP195,0.009388409970818853,2.9872580249938743,13.94535489827079,"['IL1R1', 'IRAK2', 'HSPB2', 'TAB2', 'IL1RAP', 'MAP3K14', 'MYD88', 'MAP2K6']",0.14577719728247035,0,0,8
29,ESC Pluripotency Pathways WP3931,0.009526172548427986,2.446165380536152,11.383749829580038,"['FZD1', 'SMAD1', 'FZD5', 'EGF', 'WNT7B', 'FZD9', 'GAB1', 'SMAD9', 'PIK3CD', 'FGFR3', 'MAP2K6']",0.14577719728247035,0,0,11
30,Benzene metabolism WP3891,0.009611683337305738,32.711229946524064,151.93633271671226,"['NQO1', 'EPHX1']",0.14577719728247035,0,0,2
31,Wnt signaling WP428,0.010371842961422717,2.4133513757329723,11.025783228539021,"['FZD1', 'CCND2', 'FRAT2', 'DAAM1', 'FZD5', 'DAAM2', 'WIF1', 'WNT7B', 'FZD9', 'NFATC2', 'NFATC1']",0.15223188862733342,0,0,11
32,Ferroptosis WP4313,0.014042224895981772,3.3943270300333706,14.479134732545646,"['STEAP3', 'TFRC', 'ACSL6', 'HMOX1', 'SAT1', 'SLC39A14']",0.18184379567877082,0,0,6
33,Apoptosis Modulation by HSP70 WP384,0.014366414849570972,5.041039389564859,21.388434963364286,"['FAS', 'CYCS', 'TNFRSF1A', 'HSPA1A']",0.18184379567877082,0,0,4
34,Transcription factor regulation in adipogenesis WP3599,0.014366414849570972,5.041039389564859,21.388434963364286,"['CEBPB', 'IRS1', 'IRS2', 'SLC2A4']",0.18184379567877082,0,0,4
35,Apoptosis Modulation and Signaling WP1772,0.014426757091757107,2.549979059053469,10.808521434532027,"['IL1R1', 'BAG3', 'FAS', 'CYCS', 'TNFRSF11B', 'MAP3K14', 'MYD88', 'TNFRSF1A', 'HSPA1A']",0.18184379567877082,0,0,9
36,VEGFA-VEGFR2 Signaling Pathway WP3888,0.014594872329986224,1.5687231131842232,6.631125975769455,"['SHC1', 'PLOD3', 'HSPB1', 'NRARP', 'PTPRJ', 'PLA2G5', 'NDRG1', 'APOLD1', 'TUBA1C', 'ADAMTS1', 'DNAJB4', 'TMSB10', 'ADAMTS9', 'MAP2K6', 'EGR1', 'HSP90AA1', 'EGR3', 'GAB1', 'NFATC2', 'NFATC1', 'F3', 'RAB11A', 'VEGFA', 'DNAJA1', 'NR4A1', 'TXNIP', 'FAS', 'CYCS', 'MYH9', 'DSC1', 'HSPA1A', 'EPHA2']",0.18184379567877082,0,0,32
37,Hematopoietic Stem Cell Differentiation WP2849,0.015150852781276307,3.9034835410674336,16.354418978372887,"['HES6', 'MUC1', 'CSF1', 'TRIM29', 'NFATC2']",0.18184379567877082,0,0,5
38,IL-4 signaling pathway WP395,0.015586611058180357,2.9461987093211857,12.260143371955921,"['SOCS3', 'CEBPB', 'IRS1', 'SHC1', 'PIK3CD', 'FLNA', 'IRS2']",0.18184379567877082,0,0,7
39,Interferon type I signaling pathways WP585,0.015586611058180357,2.9461987093211857,12.260143371955921,"['IFNAR2', 'SOCS3', 'IRS1', 'PDCD4', 'PIK3CD', 'IRS2', 'MAP2K6']",0.18184379567877082,0,0,7
40,Eicosanoid Synthesis WP167,0.016963548699414153,7.015490533562823,28.599969097043374,"['PNPLA3', 'ALOX12', 'PLA2G5']",0.18825401605447414,0,0,3
41,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.016963548699414153,7.015490533562823,28.599969097043374,"['FAM20C', 'FGFR3', 'NFKB2']",0.18825401605447414,0,0,3
42,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.017644799378447835,4.680582152432018,18.89698074990262,"['NQO1', 'SRXN1', 'EPHX1', 'HMOX1']",0.19115199326651822,0,0,4
43,Glioblastoma signaling pathways WP2261,0.018845058134047566,2.423972920953076,9.626819526855856,"['CCND2', 'IRS1', 'GAB1', 'PLCG2', 'PIK3CD', 'PRKCQ', 'PIK3C2A', 'IGF1R', 'MAP2K6']",0.19940701048817772,0,0,9
44,Alpha 6 Beta 4 signaling pathway WP244,0.020590680844348716,3.5634665888532244,13.836643898318737,"['LAMA5', 'SHC1', 'IRS1', 'GAB1', 'IRS2']",0.2032912107820681,0,0,5
45,Ovarian infertility WP34,0.021352533778862582,4.368185880250223,16.80259770837824,"['EGR1', 'CEBPB', 'CCND2', 'SYNE2']",0.2032912107820681,0,0,4
46,DNA damage response WP707,0.021568422449273265,2.7350829968595782,10.493214178531204,"['CCND2', 'GADD45A', 'SESN1', 'CHEK2', 'FAS', 'CYCS', 'PML']",0.2032912107820681,0,0,7
47,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.021568422449273265,2.7350829968595782,10.493214178531204,"['CEBPB', 'MAOB', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'HES5']",0.2032912107820681,0,0,7
48,FOXA2 pathway WP5066,0.022339693492534958,6.138052208835341,23.333131547848822,"['IRS1', 'FASN', 'IRS2']",0.2032912107820681,0,0,3
49,Leptin Insulin Overlap WP3935,0.022339693492534958,6.138052208835341,23.333131547848822,"['SOCS3', 'IRS1', 'IRS2']",0.2032912107820681,0,0,3
50,NOTCH1 regulation of endothelial cell calcification WP3413,0.022339693492534958,6.138052208835341,23.333131547848822,"['SAT1', 'FGFR3', 'VEGFA']",0.2032912107820681,0,0,3
51,miRNA regulation of DNA damage response WP1530,0.026342191301655236,2.610332803132265,9.492692922601048,"['CCND2', 'GADD45A', 'SESN1', 'CHEK2', 'FAS', 'CYCS', 'PML']",0.23501366749515948,0,0,7
52,Spinal Cord Injury WP2431,0.02826665095459785,2.2394184762605813,7.985928824914869,"['LGALS3', 'EGR1', 'NR4A1', 'ZFP36', 'IL1R1', 'GADD45A', 'BDNF', 'PLA2G5', 'GFAP']",0.24733319585273117,0,0,9
53,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.028979449418938114,2.5521160460595183,9.037472544676374,"['PLCG2', 'PLCE1', 'PRKCQ', 'RXRG', 'IFI44L', 'TNFRSF1A', 'NFKB2']",0.2487858393512612,0,0,7
54,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.029804690494833468,1.9534733961200998,6.862726873901771,"['SLCO1C1', 'IRS1', 'SHC1', 'FASN', 'TRIP10', 'PIK3CD', 'IRS2', 'SLC2A4', 'MAP3K6', 'PIK3C2A', 'MAP3K14', 'MAP2K6']",0.25032198876585615,0,0,12
55,Neural Crest Differentiation WP2064,0.030258701938729864,2.344820947246823,8.202116772157984,"['NOTCH3', 'SMAD1', 'HES1', 'TBX6', 'FGFR3', 'HES5', 'GFAP', 'NFKB2']",0.25032198876585615,0,0,8
56,The influence of laminopathies on Wnt signaling WP4844,0.030903123187571272,3.1515229736706245,10.957524006536396,"['CEBPB', 'HMGA2', 'HES1', 'SLC2A4', 'HES5']",0.2510878758990166,0,0,5
57,IL1 and megakaryocytes in obesity WP2865,0.03553535504159386,4.909638554216867,16.38457913594691,"['IL1R1', 'IL18', 'MYD88']",0.28095998991789,0,0,3
58,Exercise-induced Circadian Regulation WP410,0.035814680033489275,2.658674803836094,8.851785013433364,"['DNAJA1', 'CEBPB', 'RBPMS', 'PPP1R3C', 'TAB2', 'ETV6']",0.28095998991789,0,0,6
59,Oncostatin M Signaling Pathway WP2374,0.037942981087783295,2.392019964109466,7.825901735209618,"['SOCS3', 'EGR1', 'CEBPB', 'IRS1', 'SHC1', 'OSMR', 'VEGFA']",0.28663977876564173,0,0,7
60,Aryl Hydrocarbon Receptor Netpath WP2586,0.03929949126217775,2.925934803451582,9.469915869859172,"['NQO1', 'HSP90AA1', 'KLF6', 'PSRC1', 'VEGFA']",0.28663977876564173,0,0,5
61,PI3K-Akt signaling pathway WP4172,0.03953266967909679,1.6132328260961541,5.211754926259077,"['IFNAR2', 'LAMA5', 'HSP90AA1', 'CSF1', 'IRS1', 'BDNF', 'EGF', 'HGF', 'TNC', 'PIK3CD', 'OSMR', 'VEGFA', 'IGF1R', 'EFNA1', 'CCND2', 'CREB3L4', 'TNR', 'FGFR3', 'EPHA2']",0.28663977876564173,0,0,19
62,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.040682718659196156,3.447438972767038,11.038533698902846,"['HSPB8', 'HSPB1', 'NDRG1', 'RAB11A']",0.28663977876564173,0,0,4
63,miRNAs involvement in the immune response in sepsis WP4329,0.040682718659196156,3.447438972767038,11.038533698902846,"['IRF7', 'TAB2', 'MYD88', 'NFKB2']",0.28663977876564173,0,0,4
64,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.04278178391782568,8.175802139037433,25.76720857025811,"['SOCS3', 'CHI3L1']",0.28663977876564173,0,0,2
65,"Phase I biotransformations, non P450 WP136",0.04278178391782568,8.175802139037433,25.76720857025811,"['PON3', 'PON1']",0.28663977876564173,0,0,2
66,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.04278178391782568,8.175802139037433,25.76720857025811,"['LFNG', 'TBX6']",0.28663977876564173,0,0,2
67,Differentiation of white and brown adipocyte WP2895,0.04333519475765892,4.4629426798101495,14.008240577722379,"['SMAD1', 'CEBPB', 'SMAD9']",0.28663977876564173,0,0,3
68,Phytochemical activity on NRF2 transcriptional activation WP3,0.04333519475765892,4.4629426798101495,14.008240577722379,"['NQO1', 'CEBPB', 'HMOX1']",0.28663977876564173,0,0,3
69,Genotoxicity pathway WP4286,0.04346844996665775,2.52191894127378,7.908031390564722,"['ACTA2', 'ITPKC', 'DAAM1', 'SERTAD1', 'GADD45A', 'ID2']",0.28663977876564173,0,0,6
70,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.04483025606957624,2.295962314939435,7.128669124954951,"['FZD1', 'FRAT2', 'CCND2', 'FZD5', 'WIF1', 'WNT7B', 'FZD9']",0.29139666445224555,0,0,7
71,Lung fibrosis WP3624,0.04666605430160559,3.274798927613941,10.036401590960189,"['CEBPB', 'EGF', 'HGF', 'HMOX1']",0.29905710855254286,0,0,4
72,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.05191095267135101,4.090696117804551,12.101201474128555,"['NFKB2', 'VEGFA', 'TNFRSF1A']",0.3245660478508411,0,0,3
73,Cardiac Hypertrophic Response WP2795,0.05207323405079429,2.398505114083399,7.087832546089008,"['EGF', 'NFATC2', 'NRG1', 'MAP3K14', 'TNFRSF1A', 'MAP2K6']",0.3245660478508411,0,0,6
74,Biogenic Amine Synthesis WP550,0.05764000133482762,6.540106951871658,18.662446881172745,"['PNMT', 'PAH']",0.3319772228778046,0,0,2
75,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.05764000133482762,6.540106951871658,18.662446881172745,"['CSF1', 'ID2']",0.3319772228778046,0,0,2
76,Farnesoid X receptor pathway WP2879,0.05764000133482762,6.540106951871658,18.662446881172745,"['IRS2', 'FKBP5']",0.3319772228778046,0,0,2
77,Insulin signaling in adipocytes (diabetic condition) WP3635,0.05764000133482762,6.540106951871658,18.662446881172745,"['IRS1', 'SLC2A4']",0.3319772228778046,0,0,2
78,Insulin signaling in adipocytes (normal condition) WP3634,0.05764000133482762,6.540106951871658,18.662446881172745,"['IRS1', 'SLC2A4']",0.3319772228778046,0,0,2
79,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.05764000133482762,6.540106951871658,18.662446881172745,"['HES1', 'VEGFA']",0.3319772228778046,0,0,2
80,Glucocorticoid Receptor Pathway WP2880,0.06164497176986853,2.2865716429107277,6.371220025715556,"['HSP90AA1', 'ENC1', 'AMIGO2', 'BHLHE40', 'SLC19A2', 'NFKB2']",0.35060577694112727,0,0,6
81,Notch Signaling WP268,0.06583817054578243,2.4815944681716493,6.751315502390489,"['LFNG', 'NOTCH3', 'NUMBL', 'HES1', 'HES5']",0.36983169874482724,0,0,5
82,Wnt signaling in kidney disease WP4150,0.06736522126644529,2.846951859191048,7.680012492574339,"['FZD1', 'FZD5', 'WNT7B', 'FZD9']",0.37306393073665667,0,0,4
83,Calcium Regulation in the Cardiac Cell WP536,0.06822623762922408,1.7362470073904446,4.6616948578279125,"['RGS4', 'RGS17', 'PLN', 'GRK5', 'PRKAR2B', 'CAMK4', 'ATP1A4', 'GJA9', 'PRKCQ', 'YWHAG', 'YWHAH']",0.37306393073665667,0,0,11
84,Microglia Pathogen Phagocytosis Pathway WP3937,0.07127968467654627,3.5057372346528974,9.259156580875356,"['PLCG2', 'PIK3CD', 'PIK3C2A']",0.37306393073665667,0,0,3
85,Monoamine Transport WP727,0.07127968467654627,3.5057372346528974,9.259156580875356,"['IL1R1', 'TNFRSF11B', 'FBXO32']",0.37306393073665667,0,0,3
86,Urea cycle and metabolism of amino groups WP497,0.07127968467654627,3.5057372346528974,9.259156580875356,"['ARG2', 'OAT', 'PYCR1']",0.37306393073665667,0,0,3
87,p53 transcriptional gene network WP4963,0.07218944559750888,2.184587813620072,5.74210480118436,"['GLS2', 'GADD45A', 'SESN1', 'FAS', 'SAT1', 'PML']",0.37306393073665667,0,0,6
88,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.07397549908639599,5.44964349376114,14.190987920604051,"['SMAD1', 'SMAD9']",0.37306393073665667,0,0,2
89,Inflammatory Response Pathway WP453,0.07397549908639599,5.44964349376114,14.190987920604051,"['LAMA5', 'TNFRSF1A']",0.37306393073665667,0,0,2
90,RAS and bradykinin pathways in COVID-19 WP4969,0.07397549908639599,5.44964349376114,14.190987920604051,"['SERPING1', 'KLKB1']",0.37306393073665667,0,0,2
91,Metapathway biotransformation Phase I and II WP702,0.07501858624662422,1.822462138251612,4.720212256523406,"['CYP39A1', 'HS3ST3B1', 'CHST6', 'HS3ST3A1', 'CHST7', 'EPHX1', 'KCNAB1', 'NAA80', 'CYP3A7']",0.37306393073665667,0,0,9
92,Wnt signaling pathway and pluripotency WP399,0.07564043967365622,1.9010117582718076,4.90796414404881,"['FZD1', 'CCND2', 'FZD5', 'WNT7B', 'ESRRB', 'FZD9', 'PRKCQ', 'CD44']",0.37306393073665667,0,0,8
93,Focal Adhesion WP306,0.07625262760111884,1.6173163110069488,4.162492494572214,"['VASP', 'LAMA5', 'SHC1', 'EGF', 'ACTN1', 'HGF', 'TNC', 'PIK3CD', 'VEGFA', 'IGF1R', 'CCND2', 'FLNA', 'TNR']",0.37306393073665667,0,0,13
94,Ebstein-Barr virus LMP1 signaling WP262,0.0820066716233613,3.2717536813922354,8.18250766089239,"['HSP90AA1', 'MAP3K14', 'NFKB2']",0.39276879566978307,0,0,3
95,Urea cycle and associated pathways WP4595,0.0820066716233613,3.2717536813922354,8.18250766089239,"['OAT', 'GLS2', 'PYCR1']",0.39276879566978307,0,0,3
96,Neovascularisation processes WP4331,0.08338953847886778,2.6187667560321715,6.505625263677411,"['NOTCH3', 'SMAD1', 'SMAD9', 'NFKB2']",0.3952316667488004,0,0,4
97,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.08533629108773473,1.9442936332322012,4.785208896302514,"['FZD1', 'CCND2', 'FRAT2', 'FZD5', 'WIF1', 'WNT7B', 'FZD9']",0.40028878809195156,0,0,7
98,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.08981829570819772,2.0475470430107525,4.9345199569746985,"['FZD1', 'DAAM1', 'FZD5', 'SHC1', 'FZD9', 'PFN2']",0.40846754020578374,0,0,6
99,Hepatitis B infection WP4666,0.09039863723599552,1.6407307171853855,3.943539079710876,"['EGR3', 'CREB3L4', 'IRF7', 'NFATC2', 'CYCS', 'PIK3CD', 'FAS', 'NFATC1', 'TAB2', 'MYD88', 'MAP2K6']",0.40846754020578374,0,0,11
100,Dopamine metabolism WP2436,0.09156854747470317,4.6707410236822,11.166188460050346,"['NQO1', 'MAOB']",0.40846754020578374,0,0,2
101,Thiamine metabolic pathways WP4297,0.09156854747470317,4.6707410236822,11.166188460050346,"['SLC19A3', 'SLC19A2']",0.40846754020578374,0,0,2
102,Transcriptional cascade regulating adipogenesis WP4211,0.09156854747470317,4.6707410236822,11.166188460050346,"['CEBPB', 'KLF2']",0.40846754020578374,0,0,2
103,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.09337933164104845,3.0670180722891565,7.272161303103889,"['IFNAR2', 'IRF7', 'MYD88']",0.41142956458617175,0,0,3
104,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.09404104333398211,1.6736072807501379,3.95644771265467,"['FZD1', 'NOTCH3', 'CLDN4', 'FZD5', 'SHC1', 'ID2', 'WNT7B', 'FZD9', 'PIK3CD', 'MAP2K6']",0.41142956458617175,0,0,10
105,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.1010962615549072,2.424386853341277,5.555924031247321,"['IRS1', 'FBXO32', 'IGF1R', 'TNFRSF1A']",0.43808380007126446,0,0,4
106,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.10233700708888638,1.849759041375418,4.216495992199353,"['FZD1', 'EGF', 'PIK3CD', 'NRG1', 'MAP3K14', 'IGF1R', 'MAP2K6']",0.4392767757117293,0,0,7
107,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.10535766673721597,2.8863690054334987,6.495468552108218,"['FZD1', 'LAMA5', 'CCND2']",0.4414333600507619,0,0,3
108,Striated Muscle Contraction Pathway WP383,0.10535766673721597,2.8863690054334987,6.495468552108218,"['ACTA2', 'TCAP', 'TTN']",0.4414333600507619,0,0,3
109,Regulation of toll-like receptor signaling pathway WP1449,0.1057499697704023,1.7480682839173405,3.9273461135647545,"['IFNAR2', 'IRAK2', 'IRF7', 'PIK3CD', 'TAB2', 'MYD88', 'MAP2K6', 'NFKB2']",0.4414333600507619,0,0,8
110,Development and heterogeneity of the ILC family WP3893,0.11021981351821876,4.086564171122995,9.012012524049297,"['ID2', 'IL18']",0.44775868781263556,0,0,2
111,Iron metabolism in placenta WP2007,0.11021981351821876,4.086564171122995,9.012012524049297,"['STEAP3', 'TFRC']",0.44775868781263556,0,0,2
112,Aflatoxin B1 metabolism WP699,0.11218569321019879,16.33377837116155,35.73177038814962,['EPHX1'],0.44775868781263556,0,0,1
113,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.11218569321019879,16.33377837116155,35.73177038814962,['FAS'],0.44775868781263556,0,0,1
114,SCFA and skeletal muscle substrate metabolism WP4030,0.11218569321019879,16.33377837116155,35.73177038814962,['SLC2A4'],0.44775868781263556,0,0,1
115,EPO Receptor Signaling WP581,0.11790009464983016,2.725792057117358,5.827518999954113,"['SHC1', 'IRS1', 'IRS2']",0.45837398839171234,0,0,3
116,Phosphoinositides metabolism WP4971,0.12037354912037461,2.2568179717111954,4.778034495400099,"['PLCG2', 'PIK3CD', 'PLCE1', 'PIK3C2A']",0.45837398839171234,0,0,4
117,DNA damage response (only ATM dependent) WP710,0.12296287031653451,1.6804202087220954,3.521947069410135,"['CCND2', 'BCL6', 'IRS1', 'SHC1', 'WNT7B', 'PIK3CD', 'PIK3C2A', 'NFKB2']",0.45837398839171234,0,0,8
118,Toll-like Receptor Signaling Pathway WP75,0.12387136154540727,1.8536214242239806,3.87130995539677,"['IFNAR2', 'IRF7', 'PIK3CD', 'TAB2', 'MYD88', 'MAP2K6']",0.45837398839171234,0,0,6
119,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.12974874286764823,3.632204396910279,7.417525989642946,"['TNC', 'VEGFA']",0.45837398839171234,0,0,2
120,"GPCRs, Class B Secretin-like WP334",0.12974874286764823,3.632204396910279,7.417525989642946,"['CALCRL', 'ADGRG2']",0.45837398839171234,0,0,2
121,GPR40 Pathway WP3958,0.12974874286764823,3.632204396910279,7.417525989642946,"['PLCG2', 'PLCE1']",0.45837398839171234,0,0,2
122,ID signaling pathway WP53,0.12974874286764823,3.632204396910279,7.417525989642946,"['ID2', 'ELK3']",0.45837398839171234,0,0,2
123,Kynurenine Pathway and links to Cellular Senescence WP5044,0.12974874286764823,3.632204396910279,7.417525989642946,"['AADAT', 'HAAO']",0.45837398839171234,0,0,2
124,miR-509-3p alteration of YAP1/ECM axis WP3967,0.12974874286764823,3.632204396910279,7.417525989642946,"['COL5A1', 'TEAD3']",0.45837398839171234,0,0,2
125,Tryptophan catabolism leading to NAD+ production WP4210,0.12974874286764823,3.632204396910279,7.417525989642946,"['AADAT', 'HAAO']",0.45837398839171234,0,0,2
126,IL-2 signaling pathway WP49,0.13056080966385367,2.181411974977659,4.4411719488807915,"['SOCS3', 'CCND2', 'SHC1', 'NMI']",0.45837398839171234,0,0,4
127,Prader-Willi and Angelman Syndrome WP3998,0.13056080966385367,2.181411974977659,4.4411719488807915,"['PCSK1', 'CCND2', 'BDNF', 'GNRH1']",0.45837398839171234,0,0,4
128,NRF2-ARE regulation WP4357,0.13096399668334638,2.582117945466075,5.24901412539701,"['NQO1', 'CEBPB', 'HMOX1']",0.45837398839171234,0,0,3
129,TLR4 Signaling and Tolerance WP3851,0.13096399668334638,2.582117945466075,5.24901412539701,"['IRF7', 'TAB2', 'MYD88']",0.45837398839171234,0,0,3
130,Toll-like Receptor Signaling related to MyD88 WP3858,0.13096399668334638,2.582117945466075,5.24901412539701,"['IRF7', 'MYD88', 'NFKB2']",0.45837398839171234,0,0,3
131,RANKL/RANK signaling pathway WP2018,0.13307741269854118,1.9483860658357304,3.9295523043637672,"['TNFRSF11B', 'NFATC1', 'TAB2', 'MAP2K6', 'NFKB2']",0.46221544105218504,0,0,5
132,Head and Neck Squamous Cell Carcinoma WP4674,0.139034661682237,1.7859237536656891,3.5236847375401457,"['SESN1', 'GAB1', 'FGFR3', 'IGF1R', 'NFKB2', 'VEGFA']",0.4756448952287055,0,0,6
133,T-cell receptor (TCR) signaling pathway WP69,0.139034661682237,1.7859237536656891,3.5236847375401457,"['SHC1', 'NFATC2', 'FAS', 'PRKCQ', 'NFATC1', 'MAP3K14']",0.4756448952287055,0,0,6
134,Fas ligand pathway and stress induction of heat shock proteins WP314,0.14109034389283004,2.110870881259189,4.133834242728497,"['HSPB1', 'FAS', 'CYCS', 'LMNB1']",0.47907542142714676,0,0,4
135,Cell migration and invasion through p75NTR WP4561,0.14450619447055946,2.4528112449799195,4.744798779688718,"['EFNA1', 'BDNF', 'PARD3']",0.484016931334911,0,0,3
136,Prolactin Signaling Pathway WP2037,0.14692570957906664,1.7538882488479262,3.363656337961835,"['SOCS3', 'IRS1', 'SHC1', 'FLNA', 'IRS2', 'YWHAG']",0.484016931334911,0,0,6
137,Cancer immunotherapy by PD-1 blockade WP4585,0.14999206004004936,3.268716577540107,6.201320571950041,"['NFATC2', 'NFATC1']",0.484016931334911,0,0,2
138,Fatty acid transporters WP5061,0.14999206004004936,3.268716577540107,6.201320571950041,"['ACSL6', 'DBI']",0.484016931334911,0,0,2
139,Galanin receptor pathway WP4970,0.14999206004004936,3.268716577540107,6.201320571950041,"['SLC2A4', 'VEGFA']",0.484016931334911,0,0,2
140,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.14999206004004936,3.268716577540107,6.201320571950041,"['MAP3K14', 'MAP2K6']",0.484016931334911,0,0,2
141,Overview of nanoparticle effects WP3287,0.14999206004004936,3.268716577540107,6.201320571950041,"['PIK3CD', 'HMOX1']",0.484016931334911,0,0,2
142,TNF-alpha signaling pathway WP231,0.15575836699745726,1.6372812920592195,3.0444417195358926,"['HSP90AA1', 'OTUD7B', 'TAB2', 'MAP3K14', 'TNFRSF1A', 'MAP2K6', 'NFKB2']",0.49258343671324256,0,0,7
143,Aryl Hydrocarbon Receptor Pathway WP2873,0.1584833626502622,2.3358194683495888,4.302826260302874,"['NQO1', 'HSP90AA1', 'HES1']",0.49258343671324256,0,0,3
144,Tryptophan metabolism WP465,0.1584833626502622,2.3358194683495888,4.302826260302874,"['MAOB', 'AADAT', 'HAAO']",0.49258343671324256,0,0,3
145,White fat cell differentiation WP4149,0.1584833626502622,2.3358194683495888,4.302826260302874,"['CEBPB', 'EBF1', 'KLF2']",0.49258343671324256,0,0,3
146,EV release from cardiac cells and their functional effects WP3297,0.16347274493120798,8.166221628838452,14.789917489689758,['KLF2'],0.49258343671324256,0,0,1
147,Hypothetical Craniofacial Development Pathway WP3655,0.16347274493120798,8.166221628838452,14.789917489689758,['ARHGAP29'],0.49258343671324256,0,0,1
148,let-7 inhibition of ES cell reprogramming WP3299,0.16347274493120798,8.166221628838452,14.789917489689758,['EGR1'],0.49258343671324256,0,0,1
149,Macrophage markers WP4146,0.16347274493120798,8.166221628838452,14.789917489689758,['F3'],0.49258343671324256,0,0,1
150,Metabolism of alpha-linolenic acid WP4586,0.16347274493120798,8.166221628838452,14.789917489689758,['ALOX12'],0.49258343671324256,0,0,1
151,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.16347274493120798,8.166221628838452,14.789917489689758,['VEGFA'],0.49258343671324256,0,0,1
152,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.17080237917282445,2.971317452600875,5.251055027943728,"['EGF', 'HSPB1']",0.5041527870214151,0,0,2
153,Type II diabetes mellitus WP1584,0.17080237917282445,2.971317452600875,5.251055027943728,"['IRS1', 'SLC2A4']",0.5041527870214151,0,0,2
154,Non-small cell lung cancer WP4255,0.1717604175297216,1.6642974302897757,2.93191738115462,"['EGF', 'GADD45A', 'PLCG2', 'PIK3CD', 'CYCS', 'RXRG']",0.5041527870214151,0,0,6
155,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.17285238412162804,2.2294633077765607,3.9134155577769563,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.5041527870214151,0,0,3
156,Resistin as a regulator of inflammation WP4481,0.17285238412162804,2.2294633077765607,3.9134155577769563,"['PLCG2', 'PIK3CD', 'PLCE1']",0.5041527870214151,0,0,3
157,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.17454412863096117,1.924144456710298,3.358743622833862,"['HSP90AA1', 'FAS', 'TNFRSF1A', 'MAP2K6']",0.5058444492171168,0,0,4
158,Notch Signaling Pathway Netpath WP61,0.1798479926945808,1.7403969727259745,2.9859003532123363,"['HES6', 'NOTCH3', 'NUMBL', 'HES1', 'HES5']",0.5179166878230016,0,0,5
159,AGE/RAGE pathway WP2324,0.18986315093933295,1.7039988814317673,2.831111880179695,"['LGALS3', 'IRS1', 'SHC1', 'CYCS', 'MYD88']",0.5433190797320534,0,0,5
160,Ebola Virus Pathway on Host WP4217,0.1972794958603761,1.4713952572761138,2.3882713679194185,"['SOCS3', 'ACTN1', 'NEDD4', 'IRF7', 'PIK3CD', 'FLNA', 'IGF1R', 'NFKB2']",0.5610135663529445,0,0,8
161,Integrated breast cancer pathway WP1984,0.19855731396246376,1.3996303996303996,2.2627509546890416,"['BARD1', 'SMAD1', 'ITPKC', 'RASGEF1A', 'IRS1', 'GADD45A', 'CHEK2', 'FILIP1', 'PML', 'VEGFA']",0.5611402351113106,0,0,10
162,BDNF-TrkB Signaling WP3676,0.20259633581266356,2.0433400267737616,3.262273622818015,"['SHC1', 'BDNF', 'GAB1']",0.5650631807153192,0,0,3
163,IL17 signaling pathway WP2112,0.20259633581266356,2.0433400267737616,3.262273622818015,"['CEBPB', 'MAP3K14', 'IL17RB']",0.5650631807153192,0,0,3
164,Benzo(a)pyrene metabolism WP696,0.21180078388314896,5.443702714730752,8.449220764932512,['EPHX1'],0.5650631807153192,0,0,1
165,FTO Obesity Variant Mechanism WP3407,0.21180078388314896,5.443702714730752,8.449220764932512,['ARID5B'],0.5650631807153192,0,0,1
166,GABA metabolism (aka GHB) WP4157,0.21180078388314896,5.443702714730752,8.449220764932512,['PON3'],0.5650631807153192,0,0,1
167,Small Ligand GPCRs WP247,0.21180078388314896,5.443702714730752,8.449220764932512,['S1PR3'],0.5650631807153192,0,0,1
168,The alternative pathway of fetal androgen synthesis WP4524,0.21180078388314896,5.443702714730752,8.449220764932512,['HSD17B6'],0.5650631807153192,0,0,1
169,ERK Pathway in Huntington's Disease WP3853,0.21360630128139543,2.513780337309749,3.8803232934131753,"['EGF', 'BDNF']",0.5650631807153192,0,0,2
170,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.21360630128139543,2.513780337309749,3.8803232934131753,"['ACTN1', 'PRKCQ']",0.5650631807153192,0,0,2
171,NAD+ metabolism WP3644,0.21360630128139543,2.513780337309749,3.8803232934131753,"['NT5E', 'CD38']",0.5650631807153192,0,0,2
172,Overview of interferons-mediated signaling pathway WP4558,0.21360630128139543,2.513780337309749,3.8803232934131753,"['IFNAR2', 'IFNLR1']",0.5650631807153192,0,0,2
173,Nuclear receptors WP170,0.21788858021718802,1.96144578313253,2.988795078725339,"['NR4A1', 'ESRRB', 'RXRG']",0.5730595606868241,0,0,3
174,B Cell Receptor Signaling Pathway WP23,0.22600667728341087,1.5099255583126552,2.245547300325494,"['BCL6', 'SHC1', 'PLCG2', 'GAB1', 'NFATC2', 'MAP2K6']",0.5909944722066204,0,0,6
175,Myometrial relaxation and contraction pathways WP289,0.23443522057524188,1.3638101664417455,1.97831026072847,"['RGS4', 'ACTA2', 'RGS17', 'GRK5', 'PRKAR2B', 'PLCG2', 'PRKCQ', 'YWHAG', 'YWHAH']",0.6050560902376257,0,0,9
176,Nanomaterial induced apoptosis WP2507,0.23537346807046103,2.3340336134453783,3.3763705469402616,"['FAS', 'CYCS']",0.6050560902376257,0,0,2
177,Pregnane X receptor pathway WP2876,0.23537346807046103,2.3340336134453783,3.3763705469402616,"['HSP90AA1', 'CYP3A7']",0.6050560902376257,0,0,2
178,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.2425989189601351,1.5426111181461315,2.18487068341211,"['TUBA1C', 'RNF19A', 'HSPA2', 'HSPA1B', 'HSPA1A']",0.6066831181212514,0,0,5
179,Pathways Regulating Hippo Signaling WP4540,0.24521369648685265,1.464612421762157,2.058696154699419,"['PRKAR2B', 'PRKCQ', 'FGFR3', 'IGF1R', 'EPHA2', 'TEAD3']",0.6066831181212514,0,0,6
180,Synaptic Vesicle Pathway WP2267,0.24805609481093893,1.6347184986595173,2.2789616632388867,"['SNAP25', 'SLC22A3', 'SLC38A1', 'SLC17A6']",0.6066831181212514,0,0,4
181,Bladder cancer WP2828,0.24911532776472897,1.8158560166592295,2.523748102362752,"['EGF', 'FGFR3', 'VEGFA']",0.6066831181212514,0,0,3
182,Neural Crest Cell Migration during Development WP4564,0.24911532776472897,1.8158560166592295,2.523748102362752,"['BDNF', 'PIK3CD', 'EPHB1']",0.6066831181212514,0,0,3
183,Apoptosis WP254,0.2535922113413819,1.513919960228685,2.0771402258812803,"['IRF7', 'FAS', 'CYCS', 'IGF1R', 'TNFRSF1A']",0.6066831181212514,0,0,5
184,7q11.23 copy number variation syndrome WP4932,0.2542175169451823,1.3963004300298723,1.9123242159212699,"['CLIP2', 'SNAP25', 'CLDN4', 'FZD9', 'FAS', 'NRG1', 'HSPA2']",0.6066831181212514,0,0,7
185,Angiogenesis WP1539,0.2572526410156664,2.17825311942959,2.9574069369230034,"['SMAD1', 'VEGFA']",0.6066831181212514,0,0,2
186,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.2572526410156664,2.17825311942959,2.9574069369230034,"['SHC1', 'FLNA']",0.6066831181212514,0,0,2
187,Liver X receptor pathway WP2874,0.2573403116426407,4.0824432576769025,5.541328443083822,['FASN'],0.6066831181212514,0,0,1
188,miR-517 relationship with ARCN1 and USP1 WP3596,0.2573403116426407,4.0824432576769025,5.541328443083822,['ID2'],0.6066831181212514,0,0,1
189,NAD Biosynthesis II (from tryptophan) WP2485,0.2573403116426407,4.0824432576769025,5.541328443083822,['HAAO'],0.6066831181212514,0,0,1
190,Osteoblast Signaling WP322,0.2573403116426407,4.0824432576769025,5.541328443083822,['TNFRSF11B'],0.6066831181212514,0,0,1
191,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.2573403116426407,4.0824432576769025,5.541328443083822,['VEGFA'],0.6066831181212514,0,0,1
192,Serotonin Transporter Activity WP1455,0.2573403116426407,4.0824432576769025,5.541328443083822,['IL1R1'],0.6066831181212514,0,0,1
193,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.2573403116426407,4.0824432576769025,5.541328443083822,['IGF1R'],0.6066831181212514,0,0,1
194,CAMKK2  Pathway WP4874,0.26497451364534447,1.7508605851979346,2.3253558187704577,"['CAMK4', 'HMOX1', 'NFATC2']",0.6151194066766925,0,0,3
195,Folate Metabolism WP176,0.26497451364534447,1.7508605851979346,2.3253558187704577,"['SERPINA3', 'CSF1', 'NFKB2']",0.6151194066766925,0,0,3
196,Oxidative Damage WP3941,0.26497451364534447,1.7508605851979346,2.3253558187704577,"['C1R', 'GADD45A', 'CYCS']",0.6151194066766925,0,0,3
197,Cell cycle WP179,0.27221311098840034,1.3628308658591297,1.7732746693179455,"['CCND2', 'GADD45A', 'CHEK2', 'CDC7', 'YWHAG', 'YWHAH', 'SMC1B']",0.6282647225489741,0,0,7
198,Amyotrophic lateral sclerosis (ALS) WP2447,0.28094983670167983,1.6903475972856945,2.146030053359927,"['SLC1A2', 'MAP2K6', 'TNFRSF1A']",0.6282647225489741,0,0,3
199,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.28094983670167983,1.6903475972856945,2.146030053359927,"['GABRA2', 'SHC1', 'BDNF']",0.6282647225489741,0,0,3
200,p38 MAPK Signaling Pathway WP400,0.28094983670167983,1.6903475972856945,2.146030053359927,"['SHC1', 'HSPB1', 'MAP2K6']",0.6282647225489741,0,0,3
201,Allograft Rejection WP2328,0.29700746440109066,1.6338688085676039,1.983513478659347,"['COL5A1', 'FAS', 'VEGFA']",0.6282647225489741,0,0,3
202,Glycolysis and Gluconeogenesis WP534,0.29700746440109066,1.6338688085676039,1.983513478659347,"['SLC2A4', 'HK2', 'GCK']",0.6282647225489741,0,0,3
203,Neural Crest Cell Migration in Cancer WP4565,0.29700746440109066,1.6338688085676039,1.983513478659347,"['BDNF', 'PIK3CD', 'EPHB1']",0.6282647225489741,0,0,3
204,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.30021651310361497,1.485620277845479,1.7875746112756248,"['SOCS3', 'NQO1', 'HSPB1', 'NRG1']",0.6282647225489741,0,0,4
205,Aspirin and miRNAs WP4707,0.3002520202250434,3.265687583444593,3.9290567918344173,['VEGFA'],0.6282647225489741,0,0,1
206,Cytokines and Inflammatory Response WP530,0.3002520202250434,3.265687583444593,3.9290567918344173,['CSF1'],0.6282647225489741,0,0,1
207,EDA signaling in hair follicle development WP3930,0.3002520202250434,3.265687583444593,3.9290567918344173,['BMP1'],0.6282647225489741,0,0,1
208,LDLRAD4 and what we know about it WP4904,0.3002520202250434,3.265687583444593,3.9290567918344173,['NEDD4'],0.6282647225489741,0,0,1
209,PTF1A related regulatory pathway WP4147,0.3002520202250434,3.265687583444593,3.9290567918344173,['HES1'],0.6282647225489741,0,0,1
210,Urea cycle and related diseases WP4571,0.3002520202250434,3.265687583444593,3.9290567918344173,['GLS2'],0.6282647225489741,0,0,1
211,Cardiac Progenitor Differentiation WP2406,0.3010147461882997,1.9216734822271155,2.3071535436763715,"['BMP1', 'NRG1']",0.6282647225489741,0,0,2
212,Hippo-Yap signaling pathway WP4537,0.3010147461882997,1.9216734822271155,2.3071535436763715,"['NDRG1', 'TEAD3']",0.6282647225489741,0,0,2
213,Kallmann's Syndrome WP5074,0.3010147461882997,1.9216734822271155,2.3071535436763715,"['GNRH1', 'PRKCQ']",0.6282647225489741,0,0,2
214,miRNA regulation of p53 pathway in prostate cancer WP3982,0.3010147461882997,1.9216734822271155,2.3071535436763715,"['CHEK2', 'SHISA5']",0.6282647225489741,0,0,2
215,Peptide GPCRs WP24,0.3010147461882997,1.9216734822271155,2.3071535436763715,"['GNRHR', 'CCR10']",0.6282647225489741,0,0,2
216,Vitamin D in inflammatory diseases WP4482,0.3010147461882997,1.9216734822271155,2.3071535436763715,"['NFATC1', 'MAP2K6']",0.6282647225489741,0,0,2
217,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.3010147461882997,1.9216734822271155,2.3071535436763715,"['WIF1', 'PML']",0.6282647225489741,0,0,2
218,Zinc homeostasis WP3529,0.3010147461882997,1.9216734822271155,2.3071535436763715,"['SLC39A11', 'SLC39A14']",0.6282647225489741,0,0,2
219,Ras signaling WP4223,0.3049920528121653,1.2390458640458641,1.4713292458432672,"['MRAS', 'SHC1', 'PLCG2', 'GAB1', 'PLCE1', 'PIK3CD', 'PLA2G5', 'FGFR3', 'IGF1R', 'EPHA2']",0.6313491589042005,0,0,10
220,G Protein Signaling Pathways WP35,0.30526772518444856,1.3435704816615113,1.5942351863858415,"['AKAP12', 'GNA14', 'AKAP10', 'PRKAR2B', 'PRKCQ', 'PDE8B']",0.6313491589042005,0,0,6
221,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.3131152035179547,1.581033812670035,1.835871315036579,"['IFITM3', 'IFITM2', 'MAP2K6']",0.6446489484193184,0,0,3
222,Hippo-Merlin Signaling Dysregulation WP4541,0.31554176116683513,1.325305143853531,1.5286920914915818,"['PRKAR2B', 'FGFR3', 'CD44', 'IGF1R', 'EPHA2', 'TEAD3']",0.6467184744635586,0,0,6
223,Canonical and non-canonical Notch signaling WP3845,0.32275441951687817,1.8147653000594177,2.0522519405955775,"['NOTCH3', 'HES1']",0.6497931897353078,0,0,2
224,Fatty Acid Biosynthesis WP357,0.32275441951687817,1.8147653000594177,2.0522519405955775,"['FASN', 'ACSL6']",0.6497931897353078,0,0,2
225,Immune response to tuberculosis WP4197,0.32275441951687817,1.8147653000594177,2.0522519405955775,"['IFNAR2', 'IFI35']",0.6497931897353078,0,0,2
226,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.32275441951687817,1.8147653000594177,2.0522519405955775,"['CEBPB', 'ATP2C2']",0.6497931897353078,0,0,2
227,Nephrotic syndrome WP4758,0.32924253188634656,1.5315010040160641,1.701437306198761,"['CD151', 'PLCE1', 'MYH9']",0.6520293761653913,0,0,3
228,ErbB signaling pathway WP673,0.33624090743157,1.290216468590832,1.4062422675364765,"['SHC1', 'EGF', 'GAB1', 'PLCG2', 'PIK3CD', 'NRG1']",0.6520293761653913,0,0,6
229,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.34068735395403255,2.721183800623053,2.930143702878145,['NFKB2'],0.6520293761653913,0,0,1
230,Estrogen metabolism WP697,0.34068735395403255,2.721183800623053,2.930143702878145,['NQO1'],0.6520293761653913,0,0,1
231,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.34068735395403255,2.721183800623053,2.930143702878145,['CEBPB'],0.6520293761653913,0,0,1
232,Methylation Pathways WP704,0.34068735395403255,2.721183800623053,2.930143702878145,['PNMT'],0.6520293761653913,0,0,1
233,Nephrogenesis WP5052,0.34068735395403255,2.721183800623053,2.930143702878145,['RSPO3'],0.6520293761653913,0,0,1
234,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.34068735395403255,2.721183800623053,2.930143702878145,['MUC1'],0.6520293761653913,0,0,1
235,Role of Osx and miRNAs in tooth development WP3971,0.34068735395403255,2.721183800623053,2.930143702878145,['NOTCH3'],0.6520293761653913,0,0,1
236,Type III interferon signaling WP2113,0.34068735395403255,2.721183800623053,2.930143702878145,['IFNLR1'],0.6520293761653913,0,0,1
237,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.34431802942956685,1.7191106107514775,1.8328977590974918,"['IRAK2', 'MYD88']",0.6520293761653913,0,0,2
238,SARS-CoV-2 mitochondrial interactions WP5038,0.34431802942956685,1.7191106107514775,1.8328977590974918,"['IRF7', 'NFKB2']",0.6520293761653913,0,0,2
239,Unfolded protein response WP4925,0.34431802942956685,1.7191106107514775,1.8328977590974918,"['XBP1', 'TXNIP']",0.6520293761653913,0,0,2
240,Hedgehog Signaling Pathway WP4249,0.3453606146282622,1.4849701837653644,1.57877003026127,"['CCND2', 'BOC', 'PTCH2']",0.6520293761653913,0,0,3
241,IL-6 signaling pathway WP364,0.3453606146282622,1.4849701837653644,1.57877003026127,"['SOCS3', 'SHC1', 'GAB1']",0.6520293761653913,0,0,3
242,TGF-beta Receptor Signaling WP560,0.3614423072987208,1.4411764705882353,1.4666173320604938,"['SMAD1', 'EGF', 'SMAD9']",0.6646075546795124,0,0,3
243,Oxidative Stress WP408,0.36565342842099924,1.6330213903743316,1.6429327051802285,"['NQO1', 'HMOX1']",0.6646075546795124,0,0,2
244,Pre-implantation embryo WP3527,0.36565342842099924,1.6330213903743316,1.6429327051802285,"['EGR1', 'ZFP36']",0.6646075546795124,0,0,2
245,Type II interferon signaling (IFNG) WP619,0.36565342842099924,1.6330213903743316,1.6429327051802285,"['SOCS3', 'PSMB9']",0.6646075546795124,0,0,2
246,Vitamin B12 metabolism WP1533,0.36565342842099924,1.6330213903743316,1.6429327051802285,"['SERPINA3', 'NFKB2']",0.6646075546795124,0,0,2
247,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.36683164048476,1.3334792361985008,1.3372826942965437,"['LAMA5', 'CD151', 'PLCE1', 'MYH9']",0.6646075546795124,0,0,4
248,Regulatory circuits of the STAT3 signaling pathway WP4538,0.36683164048476,1.3334792361985008,1.3372826942965437,"['IFNAR2', 'SOCS3', 'IFNLR1', 'OSMR']",0.6646075546795124,0,0,4
249,IL-3 signaling pathway WP286,0.3774621473862466,1.399885255306942,1.3638871879713748,"['SHC1', 'PIK3CD', 'ENPP3']",0.6646075546795124,0,0,3
250,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.3774621473862466,1.399885255306942,1.3638871879713748,"['IFNAR2', 'CXCL17', 'IRF7']",0.6646075546795124,0,0,3
251,Biomarkers for urea cycle disorders WP4583,0.3787890406789217,2.332252527179096,2.26409442895186,['GLS2'],0.6646075546795124,0,0,1
252,Complement Activation WP545,0.3787890406789217,2.332252527179096,2.26409442895186,['C1R'],0.6646075546795124,0,0,1
253,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.3787890406789217,2.332252527179096,2.26409442895186,['HMOX1'],0.6646075546795124,0,0,1
254,LTF danger signal response pathway WP4478,0.3787890406789217,2.332252527179096,2.26409442895186,['MYD88'],0.6646075546795124,0,0,1
255,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.3787890406789217,2.332252527179096,2.26409442895186,['CLDN4'],0.6646075546795124,0,0,1
256,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.3787890406789217,2.332252527179096,2.26409442895186,['EGF'],0.6646075546795124,0,0,1
257,Nanoparticle triggered regulated necrosis WP2513,0.3787890406789217,2.332252527179096,2.26409442895186,['TNFRSF1A'],0.6646075546795124,0,0,1
258,Osteoclast Signaling WP12,0.3787890406789217,2.332252527179096,2.26409442895186,['TNFRSF11B'],0.6646075546795124,0,0,1
259,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.3787890406789217,2.332252527179096,2.26409442895186,['MYD88'],0.6646075546795124,0,0,1
260,Corticotropin-releasing hormone signaling pathway WP2355,0.37977574553114996,1.256582343830666,1.2165907861738279,"['NR4A1', 'HSP90AA1', 'IL18', 'PLCG2', 'PRKCQ']",0.6646075546795124,0,0,5
261,Mesodermal commitment pathway WP2857,0.38516569739166795,1.1912993494840736,1.1365968542973754,"['SMAD1', 'FZD5', 'SESN1', 'BHLHE40', 'ARID5B', 'HMGA2', 'TBX6']",0.671457441813061,0,0,7
262,MTHFR deficiency WP4288,0.3867150645728473,1.5551311433664374,1.4774789734178866,"['CHDH', 'CYCS']",0.6715853220635326,0,0,2
263,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.39339633610872987,1.360887996430165,1.2696236989340952,"['NFATC2', 'PRKCQ', 'MAP3K14']",0.6805906195036961,0,0,3
264,AMP-activated protein kinase (AMPK) signaling WP1403,0.4067493214954477,1.256238399670035,1.130059554829738,"['CRTC2', 'FASN', 'PIK3CD', 'SLC2A4']",0.6936936565464046,0,0,4
265,16p11.2 distal deletion syndrome WP4950,0.40746339504958135,1.4843218279047157,1.3326303392354155,"['PLN', 'NFATC2']",0.6936936565464046,0,0,2
266,TYROBP causal network in microglia WP3945,0.40746339504958135,1.4843218279047157,1.3326303392354155,"['IL18', 'IL13RA1']",0.6936936565464046,0,0,2
267,ATM Signaling Network in Development and Disease  WP3878,0.40922271165576024,1.3239986974926734,1.1829872010922657,"['CHEK2', 'HSPB1', 'CDK5R1']",0.6936936565464046,0,0,3
268,Cancer immunotherapy by CTLA4 blockade WP4582,0.41469159248488363,2.0405540720961284,1.7961368841970546,['PIK3CD'],0.6936936565464046,0,0,1
269,"Degradation pathway of sphingolipids, including diseases WP4153",0.41469159248488363,2.0405540720961284,1.7961368841970546,['NEU4'],0.6936936565464046,0,0,1
270,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.41469159248488363,2.0405540720961284,1.7961368841970546,['PRKCQ'],0.6936936565464046,0,0,1
271,NLR Proteins WP288,0.41469159248488363,2.0405540720961284,1.7961368841970546,['ERBIN'],0.6936936565464046,0,0,1
272,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.41469159248488363,2.0405540720961284,1.7961368841970546,['CCND2'],0.6936936565464046,0,0,1
273,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.42492071561411326,1.2890509406045234,1.1032377008281888,"['SMAD1', 'EGF', 'SMAD9']",0.7082011926901888,0,0,3
274,Senescence and Autophagy in Cancer WP615,0.4377599164490653,1.166347075743049,0.9635014214983618,"['CEBPB', 'IRF7', 'COL10A1', 'CD44', 'IGF1R']",0.7086021146442503,0,0,5
275,Cytosolic DNA-sensing pathway WP4655,0.4404713532480968,1.2558953763773042,1.0297210123609168,"['RNF125', 'IL18', 'IRF7']",0.7086021146442503,0,0,3
276,Gastrin signaling pathway WP4659,0.4406897776022109,1.1392535633908476,0.9335204369895531,"['EGR1', 'IRS1', 'SHC1', 'PRKCQ', 'CD44', 'VEGFA']",0.7086021146442503,0,0,6
277,Endometrial cancer WP4155,0.4461501895891874,1.1874238362174019,0.958369345622019,"['EGF', 'GADD45A', 'PIK3CD', 'FGFR3']",0.7086021146442503,0,0,4
278,MECP2 and Associated Rett Syndrome WP3584,0.4461501895891874,1.1874238362174019,0.958369345622019,"['BCL6', 'BDNF', 'IGF1R', 'FKBP5']",0.7086021146442503,0,0,4
279,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.4478888125380625,1.3604055258467023,1.092691681112687,"['PIK3CD', 'PRKCQ']",0.7086021146442503,0,0,2
280,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4478888125380625,1.3604055258467023,1.092691681112687,"['NDRG1', 'TEAD3']",0.7086021146442503,0,0,2
281,Oxidation by Cytochrome P450 WP43,0.4478888125380625,1.3604055258467023,1.092691681112687,"['CYP39A1', 'CYP3A7']",0.7086021146442503,0,0,2
282,Oxysterols derived from cholesterol WP4545,0.4478888125380625,1.3604055258467023,1.092691681112687,"['CYP39A1', 'HSD3B7']",0.7086021146442503,0,0,2
283,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.4478888125380625,1.3604055258467023,1.092691681112687,"['CREB3L4', 'CAMK4']",0.7086021146442503,0,0,2
284,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.4485217780605364,1.8136774959204867,1.454203063440847,['SMAD1'],0.7086021146442503,0,0,1
285,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.4485217780605364,1.8136774959204867,1.454203063440847,['PRKCQ'],0.7086021146442503,0,0,1
286,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4485217780605364,1.8136774959204867,1.454203063440847,['GRM3'],0.7086021146442503,0,0,1
287,Osteopontin Signaling WP1434,0.4485217780605364,1.8136774959204867,1.454203063440847,['MAP3K14'],0.7086021146442503,0,0,1
288,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.4485217780605364,1.8136774959204867,1.454203063440847,['SAMHD1'],0.7086021146442503,0,0,1
289,Small cell lung cancer WP4658,0.46064362458094693,1.1337621178225206,0.8788136920207478,"['LAMA5', 'GADD45A', 'PIK3CD', 'CYCS', 'RXRG']",0.7252347722641206,0,0,5
290,Lipid Metabolism Pathway WP3965,0.4675122025024846,1.3058823529411765,0.9929013060855676,"['PRKAR2B', 'FASN']",0.7335105246159672,0,0,2
291,Nonalcoholic fatty liver disease WP4396,0.4791772599188752,1.0704785471256242,0.7875346754885724,"['SOCS3', 'XBP1', 'IRS1', 'CYCS', 'PIK3CD', 'FAS', 'IRS2', 'TNFRSF1A']",0.7434747478384726,0,0,8
292,Ganglio Sphingolipid Metabolism WP1423,0.48039906783409,1.6321762349799733,1.196610631394677,['ST8SIA1'],0.7434747478384726,0,0,1
293,GDNF/RET signaling axis WP4830,0.48039906783409,1.6321762349799733,1.196610631394677,['IFT27'],0.7434747478384726,0,0,1
294,Nicotine Activity on Dopaminergic Neurons WP1602,0.48039906783409,1.6321762349799733,1.196610631394677,['CHRNA4'],0.7434747478384726,0,0,1
295,PPAR signaling pathway WP3942,0.4860716140357406,1.1659017020462803,0.8410806856623819,"['ACSL6', 'DBI', 'RXRG']",0.748158361287519,0,0,3
296,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.48671401085957283,1.2555532702591525,0.9040970097994895,"['IFNAR2', 'MYD88']",0.748158361287519,0,0,2
297,"GPCRs, Class A Rhodopsin-like WP455",0.4973196979012294,1.1065570045894488,0.7729546380859463,"['GPR39', 'HTR1E', 'CCR10', 'GPR19']",0.7559675178159396,0,0,4
298,G1 to S cell cycle control WP45,0.5008724772226945,1.13869431213225,0.7872975138439784,"['CCND2', 'CREB3L4', 'GADD45A']",0.7559675178159396,0,0,3
299,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5008724772226945,1.13869431213225,0.7872975138439784,"['BDNF', 'CAMK4', 'PIK3CD']",0.7559675178159396,0,0,3
300,Development of ureteric collection system WP5053,0.5054774318181262,1.2089522677757971,0.8248099657219106,"['SMAD1', 'FREM1']",0.7559675178159396,0,0,2
301,"GPCRs, Other WP117",0.5054774318181262,1.2089522677757971,0.8248099657219106,"['GNRHR', 'GPR135']",0.7559675178159396,0,0,2
302,22q11.2 copy number variation syndrome WP4657,0.5055201053548535,1.0737371953373367,0.7324685839567483,"['ACTA2', 'OAT', 'HIST1H4H', 'HES1', 'SLC2A4']",0.7559675178159396,0,0,5
303,BMP Signaling Pathway in Eyelid Development WP3927,0.5104360533845365,1.4836752033013716,0.9977566068118142,['SMAD1'],0.7559675178159396,0,0,1
304,Cell Differentiation - Index expanded WP2023,0.5104360533845365,1.4836752033013716,0.9977566068118142,['ID2'],0.7559675178159396,0,0,1
305,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5104360533845365,1.4836752033013716,0.9977566068118142,['NFKB2'],0.7559675178159396,0,0,1
306,Pyrimidine metabolism and related diseases WP4225,0.5104360533845365,1.4836752033013716,0.9977566068118142,['GLS2'],0.7559675178159396,0,0,1
307,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5154527763314435,1.1127236217597662,0.7374126120728347,"['DDX3Y', 'RNF125', 'IRF7']",0.7559675178159396,0,0,3
308,ATM Signaling Pathway WP2516,0.5237890008127206,1.165679908326967,0.7538059668759057,"['GADD45A', 'CHEK2']",0.7559675178159396,0,0,2
309,Regulation of Actin Cytoskeleton WP51,0.5267156093465546,1.0290398069671287,0.6597117778236361,"['DIAPH3', 'MRAS', 'EGF', 'ACTN1', 'PIK3CD', 'PIK3C2A', 'FGFR3']",0.7559675178159396,0,0,7
310,DNA IR-damage and cellular response via ATR WP4016,0.5343272174700796,1.0527544754821414,0.6598105627952309,"['BARD1', 'BCL6', 'CHEK2', 'PML']",0.7559675178159396,0,0,4
311,Leptin signaling pathway WP2034,0.5343272174700796,1.0527544754821414,0.6598105627952309,"['SOCS3', 'IRS1', 'SHC1', 'PLCG2']",0.7559675178159396,0,0,4
312,Canonical and non-canonical TGF-B signaling WP3874,0.5387388433878362,1.3599243435692034,0.8411463153617341,['BMP1'],0.7559675178159396,0,0,1
313,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5387388433878362,1.3599243435692034,0.8411463153617341,['CD38'],0.7559675178159396,0,0,1
314,Cysteine and methionine catabolism WP4504,0.5387388433878362,1.3599243435692034,0.8411463153617341,['SQOR'],0.7559675178159396,0,0,1
315,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5387388433878362,1.3599243435692034,0.8411463153617341,['SYTL4'],0.7559675178159396,0,0,1
316,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.5387388433878362,1.3599243435692034,0.8411463153617341,['ALOX12'],0.7559675178159396,0,0,1
317,Hedgehog Signaling Pathway Netpath WP47,0.5387388433878362,1.3599243435692034,0.8411463153617341,['PTCH2'],0.7559675178159396,0,0,1
318,Omega-3/Omega-6 FA synthesis WP4723,0.5387388433878362,1.3599243435692034,0.8411463153617341,['PLA2G5'],0.7559675178159396,0,0,1
319,Omega-9 FA synthesis WP4724,0.5387388433878362,1.3599243435692034,0.8411463153617341,['FASN'],0.7559675178159396,0,0,1
320,PPAR-alpha pathway WP2878,0.5387388433878362,1.3599243435692034,0.8411463153617341,['DBI'],0.7559675178159396,0,0,1
321,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.5387388433878362,1.3599243435692034,0.8411463153617341,['NQO1'],0.7559675178159396,0,0,1
322,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5387388433878362,1.3599243435692034,0.8411463153617341,['F3'],0.7559675178159396,0,0,1
323,TP53 network WP1742,0.5387388433878362,1.3599243435692034,0.8411463153617341,['GADD45A'],0.7559675178159396,0,0,1
324,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5416382655120798,1.1253918495297806,0.6900417858028198,"['NFATC2', 'NFATC1']",0.7559675178159396,0,0,2
325,Mitochondrial CIV Assembly WP4922,0.5416382655120798,1.1253918495297806,0.6900417858028198,"['COX19', 'COA3']",0.7559675178159396,0,0,2
326,Type 2 papillary renal cell carcinoma WP4241,0.5416382655120798,1.1253918495297806,0.6900417858028198,"['EGLN3', 'VEGFA']",0.7559675178159396,0,0,2
327,Circadian rhythm related genes WP3594,0.5560288927905429,0.9961934939610296,0.5847008489305797,"['EGR1', 'CLDN4', 'EGR3', 'ID2', 'BHLHE40', 'FAS', 'CARTPT', 'PML']",0.7633839270990841,0,0,8
328,Alzheimer's disease WP2059,0.5582270044989409,1.0196883378016086,0.594467677040495,"['FAS', 'CYCS', 'TNFRSF1A', 'CDK5R1']",0.7633839270990841,0,0,4
329,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5590174833305971,1.0877896613190732,0.6326307612737002,"['HGF', 'GAB1']",0.7633839270990841,0,0,2
330,Chemokine signaling pathway WP3929,0.5608845941781937,0.9987656352863726,0.5775263499122634,"['GRK5', 'SHC1', 'PARD3', 'PIK3CD', 'PRKX', 'CCR10']",0.7633839270990841,0,0,6
331,Airway smooth muscle cell contraction WP4962,0.5654074361151458,1.2552120776419842,0.7157328242400928,['CD38'],0.7633839270990841,0,0,1
332,Cori Cycle WP1946,0.5654074361151458,1.2552120776419842,0.7157328242400928,['SLC2A4'],0.7633839270990841,0,0,1
333,Imatinib and Chronic Myeloid Leukemia WP3640,0.5654074361151458,1.2552120776419842,0.7157328242400928,['GADD45A'],0.7633839270990841,0,0,1
334,Monoamine GPCRs WP58,0.5654074361151458,1.2552120776419842,0.7157328242400928,['HTR1E'],0.7633839270990841,0,0,1
335,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.5654074361151458,1.2552120776419842,0.7157328242400928,['FZD1'],0.7633839270990841,0,0,1
336,SARS coronavirus and innate immunity WP4912,0.5654074361151458,1.2552120776419842,0.7157328242400928,['IFNAR2'],0.7633839270990841,0,0,1
337,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.5654074361151458,1.2552120776419842,0.7157328242400928,['TNC'],0.7633839270990841,0,0,1
338,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5759213443953576,1.052613420734863,0.5808154358275381,"['CD44', 'VEGFA']",0.7752787328399044,0,0,2
339,Amino Acid metabolism WP3925,0.581450142127713,0.9886262084653505,0.5360628392447309,"['PNMT', 'ARG2', 'OAT', 'PYCR1']",0.7804124326492902,0,0,4
340,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.5905360708765528,1.1654587068472249,0.6138757244441682,['MAP2K6'],0.78336417565257,0,0,1
341,Constitutive Androstane Receptor Pathway WP2875,0.5905360708765528,1.1654587068472249,0.6138757244441682,['HSP90AA1'],0.78336417565257,0,0,1
342,MAPK pathway in congenital thyroid cancer WP4928,0.5905360708765528,1.1654587068472249,0.6138757244441682,['SHC1'],0.78336417565257,0,0,1
343,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5905360708765528,1.1654587068472249,0.6138757244441682,['FASN'],0.78336417565257,0,0,1
344,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.5923467166930221,1.0196356951871657,0.5339456353510971,"['MAP3K14', 'NFKB2']",0.783481849114317,0,0,2
345,TGF-beta Signaling Pathway WP366,0.6072745717367061,0.9498903852176637,0.47378086253464796,"['KLF6', 'SHC1', 'LIMK2', 'TNC', 'PML', 'MAP2K6']",0.7881489646808967,0,0,6
346,Integrated Cancer Pathway WP1971,0.6082924129821432,0.9886566196726625,0.4914607807412202,"['BARD1', 'CHEK2']",0.7881489646808967,0,0,2
347,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6082924129821432,0.9886566196726625,0.4914607807412202,"['ACTA2', 'TEAD3']",0.7881489646808967,0,0,2
348,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6142135594463024,1.0876724521584336,0.5301452520047709,['PLA2G5'],0.7881489646808967,0,0,1
349,miRNA targets in ECM and membrane receptors WP2911,0.6142135594463024,1.0876724521584336,0.5301452520047709,['COL5A1'],0.7881489646808967,0,0,1
350,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6142135594463024,1.0876724521584336,0.5301452520047709,['BCL2L14'],0.7881489646808967,0,0,1
351,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6142135594463024,1.0876724521584336,0.5301452520047709,['PIK3CD'],0.7881489646808967,0,0,1
352,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.6142135594463024,1.0876724521584336,0.5301452520047709,['EGR1'],0.7881489646808967,0,0,1
353,Statin inhibition of cholesterol production WP430,0.6142135594463024,1.0876724521584336,0.5301452520047709,['APOC1'],0.7881489646808967,0,0,1
354,Transcription co-factors SKI and SKIL protein partners WP4533,0.6142135594463024,1.0876724521584336,0.5301452520047709,['TEAD3'],0.7881489646808967,0,0,1
355,Pathways in clear cell renal cell carcinoma WP4018,0.6149294120037765,0.9454093328670785,0.45970320347209975,"['FASN', 'ENPP3', 'HK2', 'VEGFA']",0.7881489646808967,0,0,4
356,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6220691835608192,0.9354080709573506,0.44404192002543014,"['EGR1', 'IRS1', 'SHC1', 'BDNF', 'CAMK4', 'IRS2', 'CDK5R1']",0.7941627386073328,0,0,7
357,MET in type 1 papillary renal cell carcinoma WP4205,0.6231123025995996,0.940917516218721,0.4450808158533292,"['HGF', 'GAB1', 'PIK3CD']",0.7941627386073328,0,0,3
358,Pathways affected in adenoid cystic carcinoma WP3651,0.635359254157576,0.9230885807380466,0.4186803818012819,"['CHEK2', 'ERBIN', 'ARID5B']",0.8022665847740855,0,0,3
359,Methionine De Novo and Salvage Pathway WP3580,0.6365235980295492,1.019609479305741,0.4605920513464882,['CHDH'],0.8022665847740855,0,0,1
360,Mitochondrial Gene Expression WP391,0.6365235980295492,1.019609479305741,0.4605920513464882,['CAMK4'],0.8022665847740855,0,0,1
361,Nucleotide metabolism WP404,0.6365235980295492,1.019609479305741,0.4605920513464882,['SAT1'],0.8022665847740855,0,0,1
362,Pancreatic adenocarcinoma pathway WP4263,0.6568880193205823,0.8933122773513533,0.3754070856612671,"['EGF', 'GADD45A', 'PIK3CD', 'VEGFA']",0.8131801802272479,0,0,4
363,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.6575450617874569,0.9595539150239535,0.402285285401446,['ETV6'],0.8131801802272479,0,0,1
364,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6575450617874569,0.9595539150239535,0.402285285401446,['MRAS'],0.8131801802272479,0,0,1
365,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6575450617874569,0.9595539150239535,0.402285285401446,['UGCG'],0.8131801802272479,0,0,1
366,NAD+ biosynthetic pathways WP3645,0.6575450617874569,0.9595539150239535,0.402285285401446,['CD38'],0.8131801802272479,0,0,1
367,One-carbon metabolism WP241,0.6575450617874569,0.9595539150239535,0.402285285401446,['CHDH'],0.8131801802272479,0,0,1
368,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6590112898427283,0.8893756845564075,0.37088265677066556,"['EGR1', 'IGF1R', 'MAP2K6']",0.8131801802272479,0,0,3
369,Glycogen Synthesis and Degradation WP500,0.6673112922113467,0.881485763838705,0.35655978998550353,"['HKDC1', 'HK2']",0.8131801802272479,0,0,2
370,Metabolic reprogramming in colon cancer WP4290,0.6673112922113467,0.881485763838705,0.35655978998550353,"['FASN', 'PYCR1']",0.8131801802272479,0,0,2
371,Proteasome Degradation WP183,0.670414552841123,0.8734222604704532,0.34924577117157796,"['UBE2B', 'NEDD4', 'PSMB9']",0.8131801802272479,0,0,3
372,Ectoderm Differentiation WP2858,0.6755228563909699,0.8808485905260098,0.34552896674153155,"['FZD5', 'BOC', 'RHPN1', 'TNFRSF11B', 'NFATC1', 'KIFC3']",0.8131801802272479,0,0,6
373,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6773522819914879,0.9061711912179202,0.35301147816824613,['BCL6'],0.8131801802272479,0,0,1
374,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6773522819914879,0.9061711912179202,0.35301147816824613,['BDNF'],0.8131801802272479,0,0,1
375,Genes controlling nephrogenesis WP4823,0.6773522819914879,0.9061711912179202,0.35301147816824613,['VEGFA'],0.8131801802272479,0,0,1
376,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6773522819914879,0.9061711912179202,0.35301147816824613,['VEGFA'],0.8131801802272479,0,0,1
377,PKC-gamma calcium signaling pathway in ataxia WP4760,0.6773522819914879,0.9061711912179202,0.35301147816824613,['GNA14'],0.8131801802272479,0,0,1
378,Sleep regulation WP3591,0.6773522819914879,0.9061711912179202,0.35301147816824613,['IL18'],0.8131801802272479,0,0,1
379,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6773522819914879,0.9061711912179202,0.35301147816824613,['NFATC2'],0.8131801802272479,0,0,1
380,Melanoma WP4685,0.6815358066335313,0.8580286056506728,0.3289737345627674,"['GRM3', 'GADD45A', 'PIK3CD']",0.816049452679623,0,0,3
381,Male infertility WP4673,0.6862683756330672,0.8578382954705799,0.32296454569561955,"['NQO1', 'UBE2B', 'PON1', 'FAS']",0.819559346228466,0,0,4
382,Modulators of TCR signaling and T cell activation WP5072,0.6940217555780284,0.8361442479089538,0.3054033344816403,"['PRKCQ', 'MAP3K14']",0.8204325515642237,0,0,2
383,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6940217555780284,0.8361442479089538,0.3054033344816403,"['PDCD4', 'MAP2K6']",0.8204325515642237,0,0,2
384,Glycerolipids and Glycerophospholipids WP4722,0.6960153074808579,0.8584077014967325,0.3110728949247231,['PNPLA3'],0.8204325515642237,0,0,1
385,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6960153074808579,0.8584077014967325,0.3110728949247231,['SLC2A4'],0.8204325515642237,0,0,1
386,Signal Transduction of S1P Receptor WP26,0.6960153074808579,0.8584077014967325,0.3110728949247231,['S1PR3'],0.8204325515642237,0,0,1
387,Cannabinoid receptor signaling WP3869,0.7136001512231126,0.8154205607476636,0.27514938678597317,['PRKAR2B'],0.832533509760298,0,0,1
388,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7136001512231126,0.8154205607476636,0.27514938678597317,['HGF'],0.832533509760298,0,0,1
389,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7136001512231126,0.8154205607476636,0.27514938678597317,['FGFR3'],0.832533509760298,0,0,1
390,Sphingolipid Metabolism (general overview) WP4725,0.7136001512231126,0.8154205607476636,0.27514938678597317,['UGCG'],0.832533509760298,0,0,1
391,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7189354487419943,0.7952262945089343,0.262411718585701,"['XBP1', 'PPP1R3C']",0.8352939892312715,0,0,2
392,EGF/EGFR signaling pathway WP437,0.7196378984146339,0.8444245052589602,0.2778216680700505,"['PLSCR1', 'SHC1', 'EGF', 'LIMK2', 'NEDD4', 'GAB1', 'PLCE1']",0.8352939892312715,0,0,7
393,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.7232199361757538,0.801501086312463,0.2597199378017976,"['RBP4', 'FASN', 'DBI']",0.8373157021882136,0,0,3
394,Sphingolipid Metabolism (integrated pathway) WP4726,0.7301690223572818,0.7765274334032678,0.24420175256449028,['UGCG'],0.8432154953618356,0,0,1
395,Retinoblastoma gene in cancer WP2446,0.7329496624830149,0.7885088742065034,0.24497255930637024,"['BARD1', 'RBP1', 'CDC7']",0.8442837884298019,0,0,3
396,16p11.2 proximal deletion syndrome WP4949,0.742407862890098,0.7759291132785109,0.23111553488652578,"['MVP', 'TBX6', 'MAP2K6']",0.8483253702665681,0,0,3
397,Endothelin Pathways WP2197,0.7457805452892906,0.7411700449083627,0.21740288611365138,['CALCRL'],0.8483253702665681,0,0,1
398,Gastric Cancer Network 2 WP2363,0.7457805452892906,0.7411700449083627,0.21740288611365138,['S100A6'],0.8483253702665681,0,0,1
399,Photodynamic therapy-induced unfolded protein response WP3613,0.7457805452892906,0.7411700449083627,0.21740288611365138,['XBP1'],0.8483253702665681,0,0,1
400,Prostaglandin Synthesis and Regulation WP98,0.7457805452892906,0.7411700449083627,0.21740288611365138,['S100A6'],0.8483253702665681,0,0,1
401,Glycerophospholipid Biosynthetic Pathway WP2533,0.7604899657771337,0.7088872119347536,0.19408790387374653,['PIK3CD'],0.858654365935067,0,0,1
402,Sphingolipid pathway WP1422,0.7604899657771337,0.7088872119347536,0.19408790387374653,['UGCG'],0.858654365935067,0,0,1
403,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7605224383996307,0.7519308001235712,0.20584080307228597,"['SLCO1C1', 'PFKFB2', 'PRKCQ']",0.858654365935067,0,0,3
404,Selenium Micronutrient Network WP15,0.7636459115466053,0.7243018419489008,0.19530876220213153,"['SERPINA3', 'NFKB2']",0.8600467568161024,0,0,2
405,Rett syndrome causing genes WP4312,0.7738130298556251,0.708498023715415,0.18167660436212,"['HAP1', 'SYNE2']",0.8693455026773073,0,0,2
406,GABA receptor Signaling WP4159,0.7874077459275873,0.6520694259012016,0.1558505026085167,['GABRA2'],0.878114030384932,0,0,1
407,Nanoparticle-mediated activation of receptor signaling WP2643,0.7874077459275873,0.6520694259012016,0.1558505026085167,['PIK3CD'],0.878114030384932,0,0,1
408,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7874077459275873,0.6520694259012016,0.1558505026085167,['VEGFA'],0.878114030384932,0,0,1
409,Intraflagellar transport proteins binding to dynein WP4532,0.7997113994820886,0.626938482078669,0.14012348861488108,['IFT27'],0.8896544908663822,0,0,1
410,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8107452762049765,0.6516042780748663,0.13670746389299057,"['ACTN1', 'CACNG2']",0.8997295138372301,0,0,2
411,Acute viral myocarditis WP4298,0.8190965945075538,0.6387752962147426,0.12746969281311873,"['CYCS', 'NFKB2']",0.9036544267412912,0,0,2
412,PDGFR-beta pathway WP3972,0.8222262256503177,0.5820617966812893,0.11393260618075667,['SHC1'],0.9036544267412912,0,0,1
413,Prion disease pathway WP3995,0.8222262256503177,0.5820617966812893,0.11393260618075667,['EBF1'],0.9036544267412912,0,0,1
414,Proximal tubule transport WP4917,0.8222262256503177,0.5820617966812893,0.11393260618075667,['SLC22A6'],0.9036544267412912,0,0,1
415,Fatty acid beta-oxidation WP143,0.832517143009073,0.5619446618479812,0.10300527984234978,['ACSL6'],0.9127597592027187,0,0,1
416,3q29 copy number variation syndrome WP4906,0.8348144202586109,0.6145696700635658,0.11095799118676192,"['TFRC', 'PIGM']",0.9130782721578556,0,0,2
417,Vitamin D-sensitive calcium signaling in depression WP4698,0.8422130841460087,0.5431686693368937,0.09327413391503125,['ATP2B4'],0.9169628214107944,0,0,1
418,Integrin-mediated Cell Adhesion WP185,0.8423966139554111,0.6425174381737476,0.11019452768927064,"['VASP', 'SHC1', 'MAP2K6']",0.9169628214107944,0,0,3
419,IL-5 signaling pathway WP127,0.8513484045976434,0.5256040311813601,0.08458746879486481,['SHC1'],0.9201033826411585,0,0,1
420,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8513484045976434,0.5256040311813601,0.08458746879486481,['CYCS'],0.9201033826411585,0,0,1
421,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8513484045976434,0.5256040311813601,0.08458746879486481,['NFKB2'],0.9201033826411585,0,0,1
422,Disruption of postsynaptic signaling by CNV WP4875,0.8599554787904076,0.5091371829105474,0.07681589932578309,['YWHAG'],0.9206582184697304,0,0,1
423,MAPK Cascade WP422,0.8599554787904076,0.5091371829105474,0.07681589932578309,['MAP2K6'],0.9206582184697304,0,0,1
424,Parkinson's disease pathway WP2371,0.8599554787904076,0.5091371829105474,0.07681589932578309,['CYCS'],0.9206582184697304,0,0,1
425,Target Of Rapamycin (TOR) Signaling WP1471,0.8599554787904076,0.5091371829105474,0.07681589932578309,['DDIT4L'],0.9206582184697304,0,0,1
426,DNA Replication WP466,0.8680648137496288,0.4936683254440264,0.0698485867971037,['CDC7'],0.9271584278311763,0,0,1
427,G13 Signaling Pathway WP524,0.8757051570135524,0.47910940076965364,0.06359018974110069,['PIK3CD'],0.9331284459980478,0,0,1
428,PDGF Pathway WP2526,0.8829035978932972,0.4653824146481022,0.0579583815359164,['SHC1'],0.9386007874800238,0,0,1
429,Common Pathways Underlying Drug Addiction WP2636,0.8896856628981624,0.452418038866637,0.052881817347892934,['CAMK4'],0.9409230834247557,0,0,1
430,Copper homeostasis WP3286,0.8896856628981624,0.452418038866637,0.052881817347892934,['STEAP3'],0.9409230834247557,0,0,1
431,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8912919757276256,0.5249698119717096,0.060415211520121685,"['GADD45A', 'CYCS']",0.9409230834247557,0,0,2
432,Regulation of Microtubule Cytoskeleton WP2038,0.902095492943527,0.42853629400604315,0.0441541927057446,['CAMK4'],0.9485512766398748,0,0,1
433,Fragile X Syndrome  WP4549,0.9053396630686368,0.5856580441030843,0.05824081537568132,"['SHC1', 'BDNF', 'CAMK4', 'GAB1']",0.9485512766398748,0,0,4
434,Histone Modifications WP2369,0.9077672821480263,0.4175139502242306,0.040401668626743825,['HIST1H4H'],0.9485512766398748,0,0,1
435,Interleukin-11 Signaling Pathway WP2332,0.9077672821480263,0.4175139502242306,0.040401668626743825,['SOCS3'],0.9485512766398748,0,0,1
436,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9131108992709124,0.4070427236315087,0.03699934461147801,['FASN'],0.9485512766398748,0,0,1
437,One-carbon metabolism and related pathways WP3940,0.9131108992709124,0.4070427236315087,0.03699934461147801,['CHDH'],0.9485512766398748,0,0,1
438,Phosphodiesterases in neuronal function WP4222,0.9131108992709124,0.4070427236315087,0.03699934461147801,['PDE8B'],0.9485512766398748,0,0,1
439,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9181453085220129,0.39708228857989514,0.03391067366966437,['SYNE2'],0.9494457167670817,0,0,1
440,Pathogenic Escherichia coli infection WP2272,0.9181453085220129,0.39708228857989514,0.03391067366966437,['TUBA1C'],0.9494457167670817,0,0,1
441,Energy Metabolism WP1541,0.9228883795999173,0.38759615995931085,0.031103422835065637,['CAMK4'],0.9521864233967402,0,0,1
442,Wnt Signaling Pathway WP363,0.9273569508104578,0.37855124662340484,0.028549096146075377,['NFATC2'],0.9546321552460594,0,0,1
443,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9392698016569443,0.3537760492250537,0.022164958288509142,['CHEK2'],0.9647127759681934,0,0,1
444,Androgen receptor signaling pathway WP138,0.9473512559955108,0.4221820959788874,0.022833862247608642,"['LIMK2', 'FLNA']",0.9705621906946923,0,0,2
445,Kit receptor signaling pathway WP304,0.9492311535365672,0.332034549467317,0.01729997425783279,['SHC1'],0.9705621906946923,0,0,1
446,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9600215244844018,0.30687457490490466,0.012520351753765374,['TNIP2'],0.979394156144401,0,0,1
447,Thermogenesis WP4321,0.9710816189225898,0.3648981553806405,0.010707847940391124,"['CREB3L4', 'ACSL6']",0.9884611557265736,0,0,2
448,Genes related to primary cilium development (based on CRISPR) WP4536,0.9817114082790754,0.33114154752810215,0.006112176049803102,"['SCLT1', 'IFT27']",0.9950766789224943,0,0,2
449,Ciliopathies WP4803,0.9819547886509888,0.4262381825878369,0.007761802316557984,"['SCLT1', 'IFT27', 'PKD1L1', 'CCDC151']",0.9950766789224943,0,0,4
450,Joubert Syndrome WP4656,0.9846385632670775,0.23540566165515373,0.0036442317132834258,['FLNA'],0.9955789917478228,0,0,1
451,Pyrimidine metabolism WP4022,0.9879076944704333,0.22243356438721948,0.0027061294687389216,['ENPP3'],0.9966696252417896,0,0,1
452,Cytoplasmic Ribosomal Proteins WP477,0.9941036569204458,0.19084269221707376,0.00112860458697344,['RPS26'],0.999539951417239,0,0,1
453,Endoderm differentiation WP2853,0.9971261035772262,0.16706811831583004,0.0004808277235420818,['SESN1'],0.999539951417239,0,0,1
454,mRNA Processing WP411,0.9994292417187375,0.13039967268185537,7.444794096812745e-05,['U2AF1'],0.999539951417239,0,0,1
455,Ciliary landscape WP4352,0.999539951417239,0.24044436452276768,0.00011064154132556208,"['CDH23', 'IFT27', 'MAPRE2']",0.999539951417239,0,0,3
